INNOVA’s French seed capital company, INVENT, has been contributing to the success of Biotecgen, one of INVENT’s  start-up companies  in the biotechnology field. Il Sole 24 Ore, the principal business newspaper in Italy has published an article dedicated to the investment increase for research in the Puglia Region and refers to an important project, Optileg, that Biotecgen has developed in collaboration with the national research centre (CNR) and Coselab (research laboratory). 

For more information read the article (in Italian) “Cresce la spesa per la ricerca”, by Maria Luisa Mastrogiovanni, published in the Sole 24 Ore, 23 February 2011.